Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism

Surgery

Volumn 146, Issue 6, 2009, Pages 1035-1041

  Brunaud, Laurent ^a   Germain, Adeline ^a   Zarnegar, Rasa ^b   Rancier, Marc ^a   Alrasheedi, Saud ^a   Caillard, Cecile ^c   Ayav, Ahmet ^a   Weryha, George ^a   Mirallie, Eric ^c   Bresler, Laurent ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; PARATHYROID HORMONE;

ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CONTROLLED STUDY; HORMONE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; PARATHYROIDECTOMY; PREOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; CALCIUM; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 70549105976     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.09.041     Document Type: Article

References (25)

1. Silverberg S., Lewiecki M., Mosekilde L., Peacock M., and Rubin M. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endoc Metab 94 (2009) 351-365
2. Vestergaard P., and Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ 327 (2003) 530-535
3. Procopio M., Magro G., Cesario F., Piovesan A., Pia A., Molineri N., et al. The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed type 2 diabetes mellitus in primary hyperparathyroidism. Diabet Med 19 (2002) 958-961
4. Sancho J.J., Rouco J., Riera-Vidal R., and Sitges-Serra A. Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World J Surg 16 (1992) 732-735
5. Sitges-Serra A., and Bergenfelz A. Clinical update: sporadic primary hyperparathyroidism. Lancet 370 (2007) 468-470
6. Kiernan T.J., O'Flynn A., McDermott J., and Kearney P. Primary hyperparathyroidism and the cardiovascular system. Int J Cardiol 113 (2006) e89-e92
7. Benetos A., Gardner J., Kimura M., Labat C., Nzietchueng R., Dousset B., et al. Aldosterone and telomere length in white blood cells. J Gerontol 12 (2005) 1593-1596
8. Schmieder R., Hilgers K., Schlaich M.P., and Schmidt B.M. Renin-angiotensin system and cardiovascular risk. Lancet 369 (2007) 1208-1219
9. Pratt J. Too much aldosterone-more common than we ever realized?. Am J Hypertens 19 (2006) 25-26
10. Rodriguez E., Diaz M., Niembro E., Amato D., San-Juan E., and Paniagua R. Effect of parathyroidectomy on cardiac fibrosis and apoptosis: possible role of aldosterone. Nephron Physiol 103 (2006) 112-118
11. Seifarth C., Trenkel S., Schobel H., Hahn E., and Hensen J. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol 57 (2002) 457-465
12. Barkan A., Marilus R., Winkelsberg G., Yeshurun D., and Blum I. Primary hyperaldosteronism: possible cause of primary hyperaldosteronism in a 60-year-old woman. J Clin Endoc Metab 51 (1980) 144-147
13. Fallo F., Rocco S., Pagotto U., Zangari M., Luisetto G., and Mantero F. Aldosterone and pressor responses to angiotensin II in primary hyperparathyroidism. J Hypertens 7 (1989) S192-S193
14. Gennari C., Nami R., and Gonnelli S. Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Miner Electrolyte Metab 21 (1995) 77-81
15. Jespersen B., Brock A., Charles P., Danielsen H., Sorensen S., and Pedersen E. Unchanged noradrenaline reactivity and blood pressure after corrective surgery in primary hyperparathyroidism. Scand J Clin Lab Invest 53 (1993) 479-486
16. Kovacs L., Goth M., Szabolcs I., Dohan O., Ferencz A., and Szilagyi G. The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism. Eur J Endocrinol 138 (1998) 543-547
17. Bernini G., Moretti A., Lonzi S., Bendinelli C., Miccoli P., and Salvetti A. Renin-angiotensin-aldosteron system in primary hyperparathyroidism before and after surgery. Metabolism 48 (1999) 298-300
18. Ganguly A., Weinberger M., Passmore J., Caras J., Khairi R., Grim C., et al. The renin-angiotensin-aldosterone system and hypertension in primary hyperparathyroidism. Metabolism 31 (1982) 595-600
19. Jespersen B., Pedersen E., Charles P., Danielsen H., and Juhl H. Elevated angiotensin II and vasopressin in primary hyperparathyroidism. Angiotensin II infusion studies before and after removal of the parathyroid adenoma. Acta Endocrinol 120 (1989) 362-368
20. Richards A., Espiner E., Nicholls M., Ikram H., Hamilton E., and Maslowski A. Hormone, calcium and blood pressure relationships in primary hyperparathyroidism. J Hypertens 6 (1988) 747-752
21. Salahudeen A., Thomas T., Sellars L., Tapster S., Keavey P., Farndon J.R., et al. Hypertension and renal dysfunction in primary hyperparathyroidism: effect of parathyroidectomy. Clin Sci 76 (1989) 289-296
22. El-Gharbawy A., Nadig V., Kotchen J., Grim C., Sagar K., Kaldunski M., et al. Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension 37 (2001) 845-850
23. Schlaich M., Schobel H., Hilgers K., and Schmieder R. Impact of aldosterone on left ventricular structure and function in young normotensive and mildly hypertensive subjects. Am J Cardiol 85 (2000) 1199-1206
24. Grant F., Mandel S., Brown E., Williams G., and Seely E. Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endoc Metab 75 (1992) 988-992
25. Olgaard K., Lewin E., Bro S., Daugaard H., Egfjord M., and Pless V. Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone. Miner Electrolyte Metab 20 (1994) 309-314